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The Journal of Immunology
Fas-Activated Serine/Threonine Phosphoprotein Promotes
Immune-Mediated Pulmonary Inflammation
Maria Simarro,*,† Giorgio Giannattasio,*,†,‡ Miguel A. De la Fuente,x,{ Charaf Benarafa,‖
Kulandayan K. Subramanian,#,** Rumey Ishizawar,*,† Barbara Balestrieri,*,†
Emma M. Andersson,*,† Hongbo R. Luo,#,** Antonio Ordun˜a,†† Joshua Boyce,*,† and
Paul Anderson*,†
We generated Fas-activated serine threonine phosphoprotein (FAST)-deficient mice (FAST2/2) to study the in vivo role of FAST in
immune system function. In a model of house dust mite-induced allergic pulmonary inflammation, wild type mice develop a mixed
cellular infiltrate composed of eosinophils, lymphocytes, and neutrophils. FAST2/2 mice develop airway inflammation that is
distinguished by the near absence of neutrophils. Similarly, LPS-induced alveolar neutrophil recruitment is markedly reduced in
FAST2/2 mice compared with wild type controls. This is accompanied by reduced concentrations of cytokines (TNF-a and IL-6
and -23) and chemoattractants (MIP-2 and keratinocyte chemoattractant) in bronchoalveolar lavage fluids. Because FAST2/2
neutrophils exhibit normal chemotaxis and survival, impaired neutrophil recruitment is likely to be due to reduced production
of chemoattractants within the pulmonary parenchyma. Studies using bone marrow chimeras implicate lung resident hemato-
poietic cells (e.g., pulmonary dendritic cells and/or alveolar macrophages) in this process. In conclusion, our results introduce
FAST as a proinflammatory factor that modulates the function of lung resident hematopoietic cells to promote neutrophil re-
cruitment and pulmonary inflammation. The Journal of Immunology, 2010, 184: 5325–5332.
F
as-activated serine/threonine phosphoprotein (FAST) is a
mitochondria-associated protein that promotes the survival
of cells exposed to adverse environmental conditions (1, 2).
In stressed cells, FAST is released from mitochondria, allowing
interactions with the translational repressor T cell intracellular Ag-1
(TIA-1). By inhibiting the activity of TIA-1, FAST promotes the
translation of inhibitors of apoptosis. In this capacity, FAST acts as
a survival protein that inhibits Fas- andUV-induced apoptosis (1, 2).
In stressed cells, FAST and TIA-1 are colocalized in cytoplasmic
stress granules, a compartment that helps to reprogram protein ex-
pression to promote survival under adverse environmental con-
ditions. Thus, FAST and TIA-1 are functional antagonists that help
to determine whether stressed cells live or die.
FAST and TIA-1 are also found in the nucleus where they
regulate the alternative splicing of exons flanked by weak splice
site-recognition sequences. FAST promotes the inclusion of exon
IIIb of the fibroblast growth factor receptor 2 mRNA and exon 6 of
Fas mRNA (3, 4). Fas transcripts that include exon 6 encode
a transmembrane receptor that promotes apoptosis. Fas transcripts
lacking exon 6 encode a soluble receptor that inhibits apoptosis.
By influencing levels of the soluble and membrane-associated Fas,
FAST is likely to modulate the survival of immune cells at sites of
inflammation.
FAST is overexpressed in pancreatic tumors, where its targeted
knockdown represses the expression of transcripts encoding pro-
teins involved in cell proliferation, adhesion, andmotility (5). FAST
is also overexpressed in the cutaneous T cell lymphoma mycosis
fungoides (6). In both cases, overexpression of FAST may con-
tribute to the transformed phenotype by promoting cell survival.
Although TIA-1 has been characterized as a translational repressor,
it also indirectly regulates levels of mRNA expression (7). Indeed,
depletion of TIA-1 and T cell intracellular Ag-1 related protein
(TIAR; a closely related homolog) promotes the expression of
transcripts encoding proteins involved in inflammation, cell
growth, and proliferation (8–10). Consequently, knockdown of
TIA-1/TIAR in HeLa cells leads to increased proliferation, altered
cell cycle times, and anchorage-independent growth (11). Thus,
overexpression of FAST or reduced expression of TIA-1/TIAR
leads to increased cell survival and proliferation.
FAST mRNA is also overexpressed in PBMCs derived from
patients with asthma, atopy, type I diabetes, multiple sclerosis,
rheumatoid arthritis, and systemic lupus erythematosus (12, 13). It
is possible that FAST contributes to these immune-mediated in-
flammatory diseases by promoting the survival of inflammatory
cells and/or preventing TIA-1–mediated repression of soluble
mediators of inflammation. Mutant mice lacking TIA-1 have an
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inflammatory diathesis that is manifest by spontaneous arthritis
(10). In this article, we show that mutant mice lacking FAST are
resistant to neutrophilic pulmonary inflammation in a model of
house dust mite (HDM)-induced allergic pulmonary inflammation
and a model of LPS-induced neutrophil recruitment. These find-
ings support the concept that FAST and TIA-1 are molecular an-
tagonists that regulate cell survival and inflammation.
Materials and Methods
Generation of FAST2/2 mice
The targeting vector was designed to delete Fastk, replacing it with loxP-
flanked neo expression cassette. To generate the 59 homology arm, a 3.3-kb
fragment was amplified by PCR from the genomic DNA isolated from W4/
129S6 embryonic stem (ES) cells (Taconic Farms, Germantown, NY)
using the primers NotI 3353 (MSG 76) and SalI 6782 (MSG 77) (primer
sequences are provided in Supplemental Table I). The PCR product was
digested with NotI and SalI and cloned into NotI and SalI sites of pKO
Scrambler. To generate the 39 homology arm, a HindIII/SacI fragment of
5.8 kb from a FASTK genomic clone isolated from a 129/SvJ genomic
library (Stratagene, La Jolla, CA) was cloned into pBluescript II KS+
(Stratagene). This modified pBluescript II KS+ plasmid was digested with
XhoI and Ecl136II to excise the 39 arm, which, in turn, was ligated into
XhoI and HpaI sites of pKO Scrambler. pKO Scrambler vector (Stra-
tagene) had been previously modified so that neo expression cassette was
flanked by loxP sites. The targeting vector was linearized at a unique NotI
site and electroporated into W4/129S6 ES cells (Taconic Farms), and cells
were selected in medium containing 200 mg/ml G418 and 1 mM ganci-
clovir. Correctly targeted clones were identified by Southern blotting using
a 59 external probe (227-bp PvuII/PvuII). Three targeted clones were
identified among 192 colonies screened. Correctly targeted ES cell clones
were injected into C57BL/6J(B6) blastocysts to generate chimeras. After
germ-line transmission was confirmed by crosses with B6 females, the
resulting progeny were bred with Cre-expressing mice (C57BL/6 EIIa-cre
transgenic mice, stock #003724, The Jackson Laboratory, Bar Harbor, ME)
to remove the neo cassette. The removal of neo in the resulting pups was
confirmed by PCR using primers MSG418 and MSG419 (primer se-
quences are provided in Supplemental Table I). Sequencing of PCR
products was performed to confirm the expected structural changes.
FAST2/2 mice were backcrossed onto the B6 background (stock #000664,
The Jackson Laboratory) for 12 generations.
Murine model of HDM-induced allergic pulmonary
inflammation
Mice were sedated with 100 mg/kg ketamine and 10 mg/kg xylazine and
challenged intranasallywith10mgHDMextract (GreerLaboratories,Lenoir,
NC) in 20 ml sterile saline for 2 d a week for three consecutive weeks.
Twenty-four hours after the last challenge, mice were killed, and bron-
choalveolar lavage (BAL) fluid, lungs, blood, and spleen were collected.
Murine model of LPS-induced lung injury
Sedated mice were challenged once with 200 mg/kg LPS from Escherichia
coli 055:B5 (Sigma-Aldrich, St. Louis, MO) by intranasal instillation, and
the mice were killed 20 h later for BAL and blood collection.
Bronchoalveolar lavage
Tracheas were cannulated with an 18-gauge angiocath. Lungs were lavaged
three times with 0.7 ml cold PBS containing 0.5 mM EDTA. The cells were
counted, cytospun, and stained with Diff-Quick (Dade Behring, Deerfield,
IL) for differential analysis using morphologic criteria under a light mi-
croscope, with the evaluation of 500 cells/slide. For studies of cytokines in
BAL fluid, the first wash was collected separately and centrifuged, and the
supernatant was stored at 280˚C until analysis.
Lung histology
The left lung lobes were removed, fixed in formalin, and processed for
routine histology in paraffin. Sections were stained with naphthol AS-D
chloroacetate esterase with counterstaining by hematoxylin to depict
neutrophils.
Cell culture
RBC-depleted splenocytes (2 3 106/ml) were incubated for 72 h in the
presence of HDM extract (20 mg/ml). Supernatants were collected for
ELISA analysis. Bone marrow (BM) neutrophils were purified from 8–12-
wk-old mice, as previously described (14), and cultured at 2 3 106/ml for
24 h to study in vitro spontaneous apoptosis. Mouse embryonic fibroblasts
(MEFs) were prepared from embryonic day 9.5 embryos.
Cytokine and Ig measurements
Cytokine levels in BAL fluid and splenocyte supernatants were measured by
ELISA using matched Ab pairs from eBioscience (San Diego, CA; TNF-a,
IL-6, and MIP-2) or R&D Systems (Minneapolis, MN; IL-23 and G-CSF)
or by SearchLight Technology by Aushon (Billerica, MA; IL-1b, kerati-
nocyte chemoattractant [KC], MCP-1, and IL-17A). Serum total IgE and
HDM-specific IgG1 Ab titers were measured by ELISA, as previously
described (15).
Flow cytometry
Blood leukocyteswere stainedwith FITC-conjugated anti–Gr-1 (cloneRB6-
8C5) and PE-conjugated anti-Ly6G (clone 1A8). Gr-1 high Ly6G+ cells
were neutrophils. Early apoptosis in BM neutrophils was quantified by the
expression of membrane phosphatidylserine detected by Annexin V-FITC
binding, as recommended by the manufacturer (BD Pharmingen, San
Diego, CA). BM neutrophils were stained with PE-conjugated anti-Ly6G
(clone 1A8). Because translocation of phosphatidylserine to the external
cell surface also occurs during necrosis, it was used in conjunction with the
7-aminoactinomycin D (7AAD) nucleic dye, which stains nonviable cells.
This allowed us to differentiate early apoptotic cells (Annexin V-FITC+,
7AAD2) from late apoptotic cells (Annexin V-FITC+, 7AAD-bright).
Stained cells were acquired on a FACSCalibur flow cytometer (BD Bio-
sciences, San Jose, CA), and data were processed by FlowJo software (Tree
Star, Ashland, OR).
Blood counts
EDTA–anticoagulated blood samples were used to obtain a complete blood
count with a Hemavet Mascot Multispecies Hematology System Counter
1500R (CDC Technologies, Oxford, CT).
EZ-TAXIScan chemotaxis assay
Real-time horizontal chemotaxis assays were performed using the EZ-
TAXIScan chamber (Effector Cell Institute, Tokyo, Japan). The EZ-
TAXIScan chamber consists of an etched silicon substrate and a flat glass
plate, both of which form two compartments with a 5-mm-deep micro-
channel. BM neutrophils (1 ml, 3 3 106 /ml) were put into one hole in the
stainless steel holder with which the device is held together, and 1 ml
chemoattractant (100 nM leukotriene B4 [LTB4] or 1 mM fMLP) was put
into another contrahole. The chamber was incubated for 20 min at 37˚C.
To count the migrated cells in each channel, images of the cells in each
channel were captured at 30-s intervals using the 310 lens on a Discovery
Screening System (Universal Imaging, Dowingtown, PA). The x,y coor-
dinates of migrating neutrophils were tracked from sequential images
using DIAS imaging software (Solltech, Oakdale, IA). Average migration
speed (mm/min; migration distance between the current frame and the
previous frame divided by the time between sequential frames, 0.5 min)
was calculated at each captured frame. Directionality was calculated by
dividing the straight-line distance by the total curve-line distance that the
cell moved. Upward directionality was calculated by dividing the straight-
line distance that the cell moved in the upward direction divided by the
total curve-line distance that the cell moved.
Neutrophil-homing assay
BMwild type (WT) neutrophils were labeled for 10 min at 37˚C with 5 mM
intracellular fluorescent dyeCFSE (Molecular Probes, Eugene,OR), andBM
FAST2/2 neutrophils were labeled for 10 min at 37˚C with 7.5 mM tetra-
methylrhodamine-5-(and-6)-isothiocyanate (TRITC, Molecular Probes).
Labeled WT (CFSE+) and FAST2/2 (TRITC+) cells were mixed at a 1:1
ratio, and 23 106 cellswere injected i.v. intoWTand FAST2/2mice 6 h after
being challengedwith 200mg/kgLPS intranasally. Two hours after injection,
recipient mice were killed, BAL cell suspensions were analyzed by flow
cytometry, and the percentages ofCFSE+ andTRITC+ cellswere determined.
The homing index was calculated as the ratio of CFSE+/TRITC+ cells in
the BAL fluid divided by the ratio of CFSE+/TRITC+ cells in the input.
Assay for production of reactive oxygen species
Production of reactive oxygen species was assayed by luminol-ECL. Mice
8–12 wk old were injected i.p. with 3% thioglycollate broth (2 ml) 4 h
prior to peritoneal lavage with RPMI 1640. The proportion of neutrophils
in the peritoneal lavage was .90%, judged by light microscopy of Diff-
Quick–stained cytospin preparations. The assay mixture (0.2 ml) contained
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200 mM luminol and 2 3 105 neutrophils in HBSS. Neutrophils were
activated with zymosan (30 particles per cell; Sigma-Aldrich) in HBSS
or HBSS as a control. Chemiluminescence was measured at the indicated
intervals with a luminometer (Monolight 2010, Analytical Luminescence
Laboratory, San Diego, CA) and expressed as relative luciferase unit per
1 3 104 cells.
Generation of chimeric mice
Three-week-old recipient mice were lethally irradiated in two doses of 600
rad each (separated by 4 h). BM from donormicewas harvested from femora
and tibiae, and ∼6 3 106 cells in 0.2 ml were injected i.v. into recipient
mice. BM transplantation was performed in four groups of mice: BM from
FAST2/2 into WT (FAST2/2→WT chimeric, expressing FAST on non-
hematopoietic cells only); BM from WT into FAST2/2 mice
(WT→FAST2/2 chimeric, expressing FAST on hematopoietic cells only);
BM from FAST2/2 to FAST2/2 (FAST2/2→FAST2/2); and BM fromWT
to WT (WT→WT). Mice in the latter two groups served as negative and
positive controls for possible radiation effects. To permit complete chi-
merism, we allowed 10 wk of reconstitution time before we started ex-
periments (16). Peripheral blood counts and PCR analysis of blood DNA
were performed to confirm the hematopoietic engraftment 4 wk after BM
transplantation. We performed two separate PCR reactions to amplify
a 384-bp fragment on the WTallele with the MSG128/MSG129 primer pair
or a 669-bp fragment on the knockout allele with the MSG105/MSG133
primer pair (primer sequences are provided in Supplemental Table I).
Northern blot, immunoblot, and real-time quantitative PCR
analysis
FAST transcript and protein expression in MEFs were evaluated by
Northern blot using a FAST cDNA fragment (nucleotides 1369–1621 of
GenBank accession no. BC013547; www.ncbi.nlm.nih.gov/) and by im-
munoblot using goat polyclonal anti-FAST (Santa Cruz Biotechnology,
Santa Cruz, CA). Relative mRNA expression levels of FAST in lung and
neutrophils were measured by SYBR Green based real-time quantitative
PCR assay. GAPDH, b-actin, b-2 microglobulin, hypoxanthine phos-
phoribosyltransferase 1, and 18S were used as housekeeping genes. The
following primer pairs were used: MSG299/MSG300 (for FAST);
MSG151/MSG152 (for GAPDH); MSG287/MSG288 (for b-actin); and
MSG323/MSG324 (for hypoxanthine phosphoribosyltransferase 1) (primer
sequences are provided in Supplemental Table I). Primer pairs for b-2
microglobulin and 18S were purchased from Superarray Biosciences
(Frederick, MD). Data were analyzed using GeNorm software (Primer-
Design, Southampton, U.K.).
Statistics
All analyses were performed using Prism software (GraphPad, La Jolla,
CA). Data are expressed as mean 6 SEM and were analyzed using one-
way ANOVA with Bonferroni correction or the unpaired Student t test, as
appropriate.
Results
Generation of FAST2/2 mice
The genomic FAST locus contains 10 exons spanning 4.3 kb (Fig.
1A). We constructed a targeting vector designed to replace the
entire FAST gene with a loxP-flanked neo expression cassette
using flanking sequences isolated from W4/129S6 ES cell-derived
genomic DNA. This vector was transfected into W4/129S6 ES
cells for selection of stable integrants that were identified using
Southern blotting (Fig. 1B) and PCR (Fig. 1C). Correctly targeted
ES cell clones were injected into C57BL/6J(B6) blastocysts to
generate chimeras. After germ-line transmission was confirmed by
crosses with B6 females, the resulting progeny were bred with
Cre-expressing mice (C57BL/6 Ella-cre transgenic mice) to re-
move the neo cassette. FAST2/2 mice were backcrossed onto the
B6 background for 12 generations. MEFs prepared from FAST2/2
mice do not express FAST mRNA (Fig. 1D) or protein (Fig. 1E).
FAST2/2 mice are born at the expected Mendelian frequency
and are morphologically indistinguishable from WT mice. Eval-
uation of peripheral blood cell counts revealed no significant
differences between WT and FAST2/2 animals (data not shown).
Similarly, cell surface marker analysis of cells recovered from BM,
spleen, and thymus revealed no differences between FAST2/2 and
WT mice in the numbers of cells committed to myeloid (Gr-1, and
Mac-1) or lymphoid (CD45R/B220, CD3, CD4, and CD8) lineages
(data not shown).
FAST promotes HDM-induced allergic pulmonary
inflammation
The finding that FAST is overexpressed in PBMCs from patients
with atopy, asthma, type I diabetes, multiple sclerosis, rheumatoid
arthritis, and systemic lupus erythematosus (12, 13) led us to
examine the role of FAST in immune-mediated inflammatory
disease. We chose the HDM Ag model of allergic pulmonary in-
flammation because it uses a clinically relevant allergen with
endogenous adjuvants that break tolerance across the mucosal
barrier (17, 18). Mice were exposed to intranasal HDM extract 2 d
per week for 3 wk, a protocol that results in a Th2-associated
A
B C D E
FIGURE 1. Generation of FAST2/2 mice. A, Gene-targeting strategy. Correct targeting will delete Fast, replacing it with a loxP-flanked neo cassette. The
neo cassette is removed by crosses with EIIa-Cre mice. Exons are indicated by black boxes. E, Ecl 136II; H, HindIII; K, KpnI; N, NotI; neo, neomycin
resistance expression cassette; SI, SacI; X, XhoI;4, loxP site. B, Southern blot analysis of DraI-digested genomic DNA from WT (+/+), heterozygote (+/2),
and FAST2/2 (2/2) mice. The probe used is shown in A. C, PCR analysis of tail DNA by using primers P1 (MSG418) and P2 (MSG 419) distinguishes WT,
FAST2/2 neo+ (2/2), and FAST2/2 neo– (2/2 Dneo) alleles. Primer sequences are provided in Supplemental Table I. D, Northern analysis of mRNA from
WT and FAST2/2 primary MEFs. E, Western blot analysis of protein extracts from WT and FAST2/2 MEFs with the indicated Abs.
The Journal of Immunology 5327
 at Francis A
 Countw
ay Library of M
edicine on A
ugust 26, 2013
http://w
w
w
.jimmunol.org/
D
ow
nloaded from
 
airway inflammation characterized by BAL fluid and broncho-
vascular lymphocytosis, eosinophilia, neutrophilia, and goblet cell
hyperplasia. In HDM-challenged WT mice, the infiltrates in BAL
fluids consist of ∼49% mononuclear cells, 45% eosinophils, and
6% neutrophils. Although the absolute number of inflammatory
cells in BAL fluids obtained from WT and FAST2/2 mice was
similar, compositional analysis revealed the virtual absence of
neutrophils in FAST2/2 BAL fluid (0.323 1046 0.193 104 cells
versus 3.91 3 104 6 0.35 3 104 cells; p , 0.01) (Fig. 2A).
Histological analysis of the lungs confirmed the virtual absence of
neutrophils in .95% of the bronchovascular bundles analyzed
(Fig. 2B). In WT and FAST2/2 mice, HDM exposure increased
total serum IgE and HDM-specific serum IgG1 to similar levels,
indicating an intact immune response (Fig. 2C). Culture of WT
and FAST2/2 splenocytes from HDM-challenged mice in the
presence of HDM extract (20 mg/ml) for 4 d resulted in the se-
cretion of similar amounts of IL-4, -5, and -13 (Fig. 2D). Thus,
FAST does not modulate the induction of Th2 responses and al-
lergic eosinophilic airway inflammation to HDM, but it is required
for neutrophil recruitment to inflamed lungs.
FAST promotes LPS-induced pulmonary inflammation
Neutrophils are important effectors of the innate immune response
and are activated by Gram-negative LPS. Intranasal administration
of LPS in mice was shown to cause neutrophil recruitment and
acute lung injury (ALI) (19, 20). Therefore, we investigated the
influence of FAST deficiency on neutrophil recruitment to the lung
20 h after a single intranasal challenge with LPS from E. coli 05:
B55 (200 mg/kg). Neutrophils represent .90% of the BAL fluid
cells in an LPS-induced ALI model. We found that FAST2/2 mice
are relatively resistant to LPS-induced pulmonary inflammation
compared with WT controls. The total number of infiltrating cells
and the number of neutrophils in BAL fluid were reduced in
FAST2/2 mice (2.05 6 0.39 million neutrophils) compared with
WT controls (4.42 6 0.60 million neutrophils; p , 0.01) (Fig.
3A). Histologic analysis confirmed that FAST2/2 mice have re-
duced pulmonary neutrophil accumulation (Fig. 3B). In addition to
acute inflammation, vascular leakage is a cardinal feature of ALI.
As expected, vascular leakage assessed by total protein in BAL
fluid was less in LPS-treated FAST2/2 mice compared with WT
controls (0.866 0.09 mg/ml versus 1.446 0.23 mg/ml; p, 0.05)
(Supplemental Fig. 1A). Also consistent with reduced vascular
leakage, the accumulation of extravasated RBCs in FAST2/2 BAL
fluid was less than that in WT controls (Supplemental Fig. 1B).
Thus, the ability of FAST to regulate neutrophil recruitment to the
lung is observed in two different models of pulmonary inflam-
mation.
Effect of FAST on neutrophil function
We found that FAST mRNA is expressed in neutrophils (Sup-
plemental Fig. 2). The selective reduction in neutrophil infiltration
suggests that the function of FAST2/2 neutrophils may be im-
paired. Flow cytometric analysis revealed that LPS-treated WT
and FAST2/2 mice have similar percentages and absolute num-
bers (0.6288 6 0.1395 K/ml versus 0.5588 6 0.1229 K/ml, re-
spectively) of peripheral blood neutrophils (Fig. 4A). Although
FAST has been described as a survival factor, in vitro culture of
neutrophil populations reveals that the absence of FAST does not
affect the levels of spontaneous apoptosis, as determined by
staining with Annexin V and 7AAD (Fig. 4B). Thus, the reduced
number of neutrophils in inflamed lung is unlikely to result from
enhanced apoptosis of cells lacking FAST. We next investigated
whether defective chemotaxis of FAST2/2 neutrophils might ac-
count for the reduced recruitment of neutrophils to the lungs in
LPS-treated FAST2/2 mice. BM-derived neutrophils from WT or
FAST2/2 mice were exposed to the potent chemoattractant LTB4
in a chemotactic chamber (EZ-TAXIScan), and single motile cells
were tracked for 20 min with frames taken every 30 s. The cell
paths were charted, and average cell speed and directionality were
quantified (Fig. 5A). Surprisingly, FAST2/2 neutrophils moved
significantly faster than did WT neutrophils (12.75 6 0.56 mm/
min versus 10.34 6 0.39 mm/min; p , 0.001) (Fig. 5B). The
directionality and upward directionality of WT and FAST2/2
neutrophils were not significantly different (Fig. 5B). Similar re-
sults were obtained using fMLP instead of LTB4 (Supplemental
Fig. 3). Our results indicate that FAST2/2 neutrophils are equally
as capable as WT neutrophils of chemotaxing and reaching their
final target. Thus, the reduced number of pulmonary neutrophils in
FAST2/2 mice is probably not due to defective neutrophil survival
or chemotaxis.
A B
C
D
FIGURE 2. Lung inflammation in HDM-treated WT
and FAST2/2 mice. A, Total and differential cell counts
in BAL fluid. EOS, eosinophils; LYM, lymphocytes;
NEU, neutrophils; TCN, total cell number. ppp , 0.01.
B, Histological examination of inflammation around
the bronchovascular bundles. Neutrophils (red-stained
cells; arrow) were detected with chloroacetate esterase
substrate (original magnification 340). Scale bar, 10
mm. C, Serum concentration of total IgE and HDM-
specific IgG1 Ab titers. D, Cytokine profile of sple-
nocytes harvested from mice 24 h after final HDM
exposure. Supernatants were collected after 72 h
in vitro culture in the absence (gray bars) or presence of
HDM (20 mg/ml). Control (Ctrl) WT and FAST2/2
mice were challenged with sterile saline. Means 6
SEM are shown (n = 10). Black bars represent WT
mice, and white bars represent FAST2/2 mice.
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We also compared the response of WTand FAST2/2 neutrophils
to zymosan particles. The phagocytosis of zymosan particles and
the production of reactive oxygen species were similar in WT and
FAST2/2 neutrophils (Supplemental Fig. 4). Thus, FAST does not
seem to affect the survival, chemotaxis, or phagocytic or killing
activity of neutrophils.
FAST exerts its proinflammatory effects within the lung
We next compared the ability of fluorescently labeled WT or
FAST2/2 BM-derived neutrophils to migrate to the lungs of LPS-
treated WT or FAST2/2 mice. Equivalent amounts of CFSE-la-
beled WT neutrophils and TRITC-labeled FAST2/2 neutrophils
were injected i.v. into WT and FAST2/2 mice 6 h after intranasal
LPS challenge. Two hours later, mice were sacrificed, and BAL
fluid was analyzed using flow cytometry. Homing index was
calculated as the ratio of CFSE+/TRITC+ cells. The homing index
was very close to 1 in all experiments (Fig. 6A shows represen-
tative experiments), indicating that WT CFSE+ cells and FAST2/2
TRITC+ cells have a similar ability to migrate to lungs of LPS-
treated WT or FAST2/2 mice. We next calculated the absolute
number of fluorescently labeled cells in BAL fluid of LPS-treated
WTand FAST2/2 mice. In the BAL fluid of LPS-treated FAST2/2
recipient mice, the absolute numbers of WT CFSE+ cells (3117 6
606.7 cells) and FAST2/2 TRITC+ cells (3050 6 632.5 cells)
were reduced compared with the absolute numbers of WT CFSE+
cells (6188 6 1034 cells; p , 0.05) and FAST2/2 TRITC+ cells
(6188 6 1034 cells; p , 0.05) in LPS-treated WT mice (Fig. 6B).
These results indicate that the reduced recruitment of neutrophils
to FAST2/2 lung is not due to defective neutrophil function and
that FAST exerts its proinflammatory effects within the lung.
To determine the basis for the reduced neutrophil recruitment in
FAST2/2 mice, we quantified proinflammatory cytokines and
chemoattractants in BAL fluid. BAL fluid from LPS-treated
FAST2/2 mice contains significantly less TNF-a (286.2 6 67.35
pg/ml versus 788.06 141.8 pg/ml; p, 0.01), IL-6 (404.86 95.49
pg/ml versus 859.0 6 148.7 pg/ml; p , 0.05), IL-23 (9.929 6
3.669 pg/ml versus 45.62 6 7.814 pg/ml; p , 0.001), MIP-2
(97.92 6 10.68 pg/ml versus 201.2 6 30.88; p , 0.01), and KC
(197.56 43.26 pg/ml versus 385.4 6 30.29 pg/ml; p, 0.01) than
LPS-treated WT controls (Fig. 6C). In contrast, levels of G-CSF,
IL-1b, and MCP-1 in BAL fluid were similar in both groups of
mice. IL-17A was below the detection limit (0.78 pg/ml) in BAL
fluid of mice of both genotypes. These results suggest that FAST
mediates its proinflammatory effects within the lung parenchyma
by promoting the production of proinflammatory cytokines and
chemoattractants.
FAST expression in lung resident cells of hematopoietic origin
is necessary for neutrophil recruitment to the lung
We next investigated the relative contribution of hematopoietic and
nonhematopoietic cells to the reduced proinflammatory cytokine
and chemokine production in the lung parenchyma of LPS-treated
FAST2/2 mice. We created chimeras and controls by transferring
BM between WT and FAST2/2 mice. Engraftment efficiency was
monitored by WBC counts and PCR (Supplemental Fig. 5). In all
groups, mice were assessed 20 h after LPS inhalation. Consistent
with the findings in FAST2/2 mice, FAST2/2→FAST2/2 mice
(where FAST2/2 BM was injected into irradiated FAST2/2 mice)
had significantly fewer neutrophils (1.435 6 0.2607 million cells)
in BAL fluid than WT→WT mice (3.433 6 0.4740 million cells;
p , 0.01) (Fig. 7). In WT→FAST2/2 chimeric mice, the number
of neutrophils in the BAL fluid was similar to that of WT→WT
mice (Fig. 7). These results indicate that nonhematopoietic cells
A
B
FIGURE 3. Lung inflammation in LPS-treated WT and FAST2/2 mice. A,
Total and neutrophil counts in BAL fluid from LPS-treated WT (black bars) or
FAST2/2 (white bars)mice (n= 10 for each group). ppp, 0.01.B, Histological
examination of lung parenchyma and alveolar space in LPS-treated WT and
FAST2/2 mice. Neutrophils (red-stained cells; arrow) were detected with
chloroacetate esterase substrate (originalmagnification340). Scale bar, 10mm.
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FIGURE 4. A, Representative FACS analysis of whole blood taken from
LPS-treated mice. Neutrophils were stained with Abs to Mac-1 and Ly6G.
B, FACS analysis of neutrophil spontaneous death. BM neutrophils were
cultured in RPMI 1640 medium containing 10% FBS at a density of 2 3
106 cells/ml for 24 h. Apoptotic cells were detected by Annexin V-FITC
and 7AAD staining.
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are not a major determinant of the reduced inflammatory response
in FAST2/2 lungs. In contrast, FAST2/2→WT chimeric mice
showed a reduction in the number of neutrophils in the BAL fluid
(1.8746 0.4698 million cells; p, 0.05) that was similar to that of
FAST2/2→FAST2/2 controls. As shown in Supplemental Fig. 6,
TNF-a levels in the BAL fluid samples correlated well with
neutrophil numbers. These results suggest that FAST expression in
lung resident cells of hematopoietic origin (alveolar macrophages
and/or dendritic cells [DCs]) is required to produce the in-
flammatory cytokines and/or neutrophil chemoattractants that
mediate pulmonary inflammation.
Discussion
FAST is a serine/threonine phosphoprotein that interacts with the
adenine/uridine-rich element RNA-binding protein TIA-1. TIA-1 is
a translational repressor that inhibits the production of multiple
proinflammatory mediators, including TNF-a, IL-1b and -6, cy-
clooxygenase 2, and matrix metalloproteinase 13 (8, 10, 21). Mice
lacking TIA-1 overexpress these inflammatory mediators and
develop spontaneous arthritis, a manifestation of a general in-
flammatory diathesis (22). Because FAST antagonizes TIA-1–
induced translational repression, we predicted that FAST2/2 mice
would produce less inflammatory mediators and exhibit less in-
flammation than WT controls. Consistent with this prediction, we
found that FAST2/2 mice are resistant to immune-mediated pul-
monary inflammation.
In a well-established model of HDM-induced allergic pulmonary
inflammation, we found that FAST2/2 mice and WT controls
showed similar eosinophilic airway inflammation. The production
of Th2 cytokines that drive eosinophilia in this model was also
similar in WT and FAST2/2 mice. Interestingly, we found a strik-
ing reduction in neutrophils in pulmonary tissue and BAL fluids of
HDM-treated FAST2/2 mice. Neutrophils represent a small per-
centage of the overall inflammatory cell response in this model of
asthma. Patients with severe and fatal asthma have increased
numbers of neutrophils in the airways (23). Several reports have
suggested an important role for neutrophils in airway remodeling.
Asthmatic patients have greater numbers of subepithelial neu-
trophils positive for TGF-b than do normal control subjects (24).
TGF-b has an important role in tissue repair and fibrosis, and
its levels may correlate with the thickness of subepithelial base-
ment membrane (as an indicator of airway fibrosis) (25). In addi-
tion, neutrophil-derived oxidative stress is known to cause mucin
MUC5AC synthesis via ligand-independent epidermal growth
factor receptor (26). Increased production of mucin MUC5AC
causes goblet cell hyperplasia (27). In HDM-treated FAST2/2
mice, there was a trend toward reduced numbers of goblet cells
(detected by Alcian blue/periodic acid-Schiff staining) compared
0.2
0.4
S
p
e
e
d
 
(
μm
/
m
i
n
)
D
i
r
e
c
t
i
o
n
a
l
i
t
y
U
p
w
a
r
d
D
i
r
e
c
t
i
o
n
a
l
i
t
y
B
A
0.6
0.8
/ /
0
  0
50
 50
-50 100
100
150
200
150
-100 0
  0
50
 50
-50 100
100
150
200
150
-100
***
NS
 0
 6
 8
 0
NS
0.2
0.4
0.6
0.8
 0
 10
 12
 14
 4
 2
FIGURE 5. Chemotaxis in FAST2/2 neutrophils. BM neutrophils iso-
lated from WT and FAST2/2 mice were exposed to 100 nM LTB4 in
a chemotactic chamber EZ-TAXIScan, and single motile cells were
tracked for 20 min with frames taken every 30 s. A, Cell paths are shown
starting at each origin. Units in x- and y-axes, mm. B, Parameters of mo-
tility, such as average migration speed, directionality, and upward di-
rectionality, are shown. Results are mean 6 SEM of n = 20 cells for each
group from three movie sequences. Black bars represent WT mice, and
white bars represent FAST2/2 mice. pppp , 0.001.
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FIGURE 6. Recruitment of adoptively transferred neutrophils in LPS-
treated WT and FAST2/2 mice. A mixture of equal numbers of CFSE-
labeled WT neutrophils and TRITC-labeled FAST2/2 neutrophils was
injected i.v. into WT and FAST2/2 mice that had been challenged with
LPS for 6 h. A, FACS analysis of the recipient BAL fluid 2 h after the
injection. The homing index (HI) represents the ratio of CFSE+/TRITC+
cells. B, Absolute number of adoptively transferred neutrophils recruited to
the alveolar space. Data shown are means 6 SEM for six mice. C, Levels
of several cytokines and chemoattractants in BAL fluid of mice 20 h after
intranasal instillation of LPS. Means 6 SEM are shown (n = 8–10). Black
bars represent WT mice, and white bars represent FAST2/2 mice. pp ,
0.05; ppp , 0.01; pppp , 0.001.
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withWT controls, but the difference was not statistically significant
(31.14 6 3.885/mm [n = 30] versus 40.56 6 3.682/mm [n = 29];
mm of perimeter of the bronchus). The role of neutrophils in mouse
models of asthma is largely unexplored. In these models, neu-
trophils increase transiently in the BAL fluid (28) as a result of
challenge with a large allergen bolus.
The neutrophil phenotype prompted us to examine the role of
FAST in the development of LPS-mediated ALI. Recruitment of
neutrophils into the lung is a pathological hallmark of this model
of ALI (29). TLR4 is the most important cellular receptor for LPS
and is essential for LPS-induced neutrophil migration into the
lung, as shown by the absence of a response in TLR4-deficient
mice (30–32). In lung tissue, nonhematopoietic radioresistant
cells (such as epithelial and endothelial cells) and hematopoietic
cells (such as alveolar, lung macrophages, and DCs) are in-
strumental in inducing innate responses to LPS (33–37). In this
report, we conclude that FAST expression on lung cells of he-
matopoietic origin is crucial in mediating LPS-induced neutrophil
migration to the lung. The reduction in neutrophil infiltration in
the lungs of LPS-treated FAST2/2 mice is accompanied by re-
duced levels of proinflammatory cytokines (e.g., TNF-a and IL-6
and -23) and neutrophil chemoattractants (e.g., MIP-2 and KC) in
the BAL fluids. Interestingly, KC and MIP-2 are the chemo-
attractants that recruit neutrophils to the lung in mice challenged
with HDM Ag (38). These same chemokines are likely to con-
tribute to neutrophil infiltration in the LPS model as well. Al-
though the inhibition of neutrophil recruitment is more
pronounced in the HDM model compared with the LPS model,
this may reflect differences in the delivered dose of LPS rather
than a role for FAST in the adaptive immune response to HDM
Ag. The finding that FAST2/2 mice develop pulmonary in-
flammation in the absence of neutrophilia may allow us to de-
termine the importance of neutrophils for the development of
airway hyperreactivity, a phenomenon that can be dissociated
from pulmonary inflammation.
Alveolar macrophages are lung resident cells of hematopoietic
origin that play a very important role in the development of ALI.
Activated pulmonary macrophages release the cytokines TNF-a
and IL-1b, -6, and -8, as well as the chemokines MCP-1 and MIP-
1b and -2 (39). Depletion of alveolar macrophages by clodronate-
liposomes resulted in decreased neutrophilic influx and pulmonary
TNF-a production following exposure to aerolized LPS (34).
Numerous studies have reported varying effects of macrophage
depletion on the development of neutrophilic lung injury in in-
fectious models of lung inflammation with Gram-negative bacte-
ria. Although some investigators found decreased expression of
TNF-a and MIP-2 in association with decreased neutrophil influx
in Pseudomonas aeruginosa pneumonia (40), other investigators
described increased neutrophil influx into the lungs following
inoculation with Klebsiella pneumonia (41). These varying effects
on neutrophil influx are likely due to impaired clearance of bac-
teria in the absence of alveolar macrophages that is a persistent
stimulus for neutrophil influx. It will be interesting to characterize
the role of FAST in different infectious models of lung in-
flammation.
Lung-resident DCs participate in innate and adaptive immunity
in the lung. As a result of activation through TLRs, DCs release
cytokines (e.g., TNF-a and IL-1b and -6) and chemokines (e.g.,
MIP-1a and -2) (42) that promote acute lung inflammation. DCs
are the most potent APCs and generate robust Th1 and Th2 im-
mune responses (43). DCs bridge innate and adaptive responses in
the model of HDM-induced allergic pulmonary inflammation. An
emerging theme in the field of lung immunology is that structural
cells of the airways, such as epithelial cells, endothelial cells, and
fibroblasts, produce activating cytokines that determine the
quantity and quality of the lung immune response. It was recently
reported that TLR4 triggering on epithelium plays a central role in
controlling the function of lung DCs through the release of innate
cytokines (GM-CSF, IL-25 and -33, and thymic stromal lym-
phopoietin) that promote DC maturation and boost Th2 cytokine
production (33, 44–47). The HDM extracts are known to contain
LPS (48, 49). WT→TLR42/2 chimeric mice failed to develop the
salient features of allergic inflammation, such as airway eosino-
philia, goblet cell hyperplasia, and peribronchial and perivascular
inflammation, following exposure to HDM (33). Our study
showed that HDM-treated FAST2/2 mice developed eosinophilic
airway inflammation similar to that of WT controls, suggesting
that FAST is not a major determinant of the activation of the
epithelium-DC axis by LPS.
There are many ways in which the absence of FAST could
produce the observed phenotype; the translation of one or more of
these transcripts could be enhanced in the absence of FAST-me-
diated repression of TIA-1. This regulation may occur in a cell-
type–restricted manner, because TIA-1 represses the translation of
TNF-a in macrophages but not in T cells. Cells within the in-
flamed lung that may produce neutrophil chemoattractants include
alveolar macrophages, pulmonary DCs, infiltrating T cells, or
pulmonary epithelial cells. The reduced expression of a pivotal
cytokine (e.g., TNF-a or IL-6) could indirectly reduce the ex-
pression of the other mediators by dampening inflammation.
Further studies will be required to identify cells that require FAST
for the production of inflammatory mediators. Also, the absence of
FAST may prevent the survival of key lung-resident cells of he-
matopoietic origin, or altered splicing of Fas receptor mRNA
could increase the production of soluble Fas. This could increase
the survival of immunomodulatory cells to inhibit pulmonary in-
flammation. In addition, it is known that alternate splicing of key
signaling molecules in TLR cascades dramatically alters the sig-
naling capacity of inflammatory cells (50). Because more than one
of these mechanisms may conspire to dampen pulmonary in-
flammation, nonbiased analysis of inflammatory mediator pro-
duction and infiltrating immune cells will be required to shed light
on the mechanism by which FAST promotes immune-mediated
pulmonary inflammation.
The finding that FAST is overexpressed in peripheral blood cells
from patients with many immune-mediated inflammatory diseases
suggests that FAST may be an important mediator of this process.
Future studies designed to determine the mechanism by which
FAST promotes inflammation could identify targets for a new class
of anti-inflammatory drugs.
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